Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -27.92% | -62.93% |
04-11 | Syncona to Sell Stake in Portfolio Company to Century Therapeutics | MT |
02-20 | Syncona’s Takeover of Freeline Therapeutics Becomes Effective | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-62.93% | 0 | |
+9.17% | 3,042B | |
+6.91% | 83.84B | |
+3.74% | 77.3B | |
-13.64% | 53.92B | |
-24.95% | 47.93B | |
+25.57% | 47.66B | |
+19.54% | 43.81B | |
+64.81% | 37.42B | |
-14.63% | 25.93B |
- Stock Market
- Equities
- MYRN Stock
- News Myriad Group AG
- Myriad : Syncona's Achilles Therapeutics to Continue Clinical Trials on T Cell Therapies to Treat Solid Tumors